19-40718299-G-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_025194.3(ITPKC):​c.1155+9G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.125 in 1,503,416 control chromosomes in the GnomAD database, including 12,452 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.10 ( 1034 hom., cov: 32)
Exomes 𝑓: 0.13 ( 11418 hom. )

Consequence

ITPKC
NM_025194.3 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity no assertion criteria provided U:1B:1

Conservation

PhyloP100: 0.915

Publications

89 publications found
Variant links:
Genes affected
ITPKC (HGNC:14897): (inositol-trisphosphate 3-kinase C) This gene encodes a member of the inositol 1,4,5-trisphosphate [Ins(1,4,5)P(3)] 3-kinase family of enzymes that catalyze the phosphorylation of inositol 1,4,5-trisphosphate to 1,3,4,5-tetrakisphosphate. The encoded protein is localized to the nucleus and cytoplasm and has both nuclear import and nuclear export activity. Single nucleotide polymorphisms in this gene are associated with Kawasaki disease.[provided by RefSeq, Sep 2009]
COQ8B (HGNC:19041): (coenzyme Q8B) This gene encodes a protein with two copies of a domain found in protein kinases. The encoded protein has a complete protein kinase catalytic domain, and a truncated domain that contains only the active and binding sites of the protein kinase domain, however, it is not known whether the protein has any kinase activity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
COQ8B Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • nephrotic syndrome, type 9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 19-40718299-G-C is Benign according to our data. Variant chr19-40718299-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 4277.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.139 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITPKCNM_025194.3 linkc.1155+9G>C intron_variant Intron 1 of 6 ENST00000263370.3 NP_079470.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITPKCENST00000263370.3 linkc.1155+9G>C intron_variant Intron 1 of 6 1 NM_025194.3 ENSP00000263370.1

Frequencies

GnomAD3 genomes
AF:
0.102
AC:
15556
AN:
152030
Hom.:
1032
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0323
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.144
Gnomad ASJ
AF:
0.114
Gnomad EAS
AF:
0.0745
Gnomad SAS
AF:
0.117
Gnomad FIN
AF:
0.151
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.129
Gnomad OTH
AF:
0.101
GnomAD2 exomes
AF:
0.121
AC:
20177
AN:
167104
AF XY:
0.122
show subpopulations
Gnomad AFR exome
AF:
0.0300
Gnomad AMR exome
AF:
0.192
Gnomad ASJ exome
AF:
0.107
Gnomad EAS exome
AF:
0.0675
Gnomad FIN exome
AF:
0.138
Gnomad NFE exome
AF:
0.126
Gnomad OTH exome
AF:
0.123
GnomAD4 exome
AF:
0.128
AC:
172968
AN:
1351266
Hom.:
11418
Cov.:
33
AF XY:
0.128
AC XY:
84775
AN XY:
661624
show subpopulations
African (AFR)
AF:
0.0275
AC:
828
AN:
30126
American (AMR)
AF:
0.186
AC:
5341
AN:
28752
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
2057
AN:
19804
East Asian (EAS)
AF:
0.120
AC:
4651
AN:
38770
South Asian (SAS)
AF:
0.125
AC:
8774
AN:
70006
European-Finnish (FIN)
AF:
0.145
AC:
5795
AN:
39942
Middle Eastern (MID)
AF:
0.111
AC:
493
AN:
4422
European-Non Finnish (NFE)
AF:
0.130
AC:
138148
AN:
1063616
Other (OTH)
AF:
0.123
AC:
6881
AN:
55828
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
7763
15526
23290
31053
38816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5218
10436
15654
20872
26090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.102
AC:
15565
AN:
152150
Hom.:
1034
Cov.:
32
AF XY:
0.104
AC XY:
7718
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.0322
AC:
1338
AN:
41524
American (AMR)
AF:
0.144
AC:
2200
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.114
AC:
397
AN:
3470
East Asian (EAS)
AF:
0.0744
AC:
385
AN:
5174
South Asian (SAS)
AF:
0.118
AC:
570
AN:
4824
European-Finnish (FIN)
AF:
0.151
AC:
1604
AN:
10594
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
0.129
AC:
8802
AN:
67976
Other (OTH)
AF:
0.0993
AC:
210
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
716
1432
2148
2864
3580
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.123
Hom.:
675
Bravo
AF:
0.0977
Asia WGS
AF:
0.0860
AC:
299
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Reclassified - variant of unknown significance Uncertain:1
Mar 15, 2010
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

ITPKC-related disorder Benign:1
Nov 15, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
18
DANN
Benign
0.76
PhyloP100
0.92
PromoterAI
0.052
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28493229; hg19: chr19-41224204; COSMIC: COSV54575926; COSMIC: COSV54575926; API